Naomi Douglas

9.9k total citations
6 papers, 28 citations indexed

About

Naomi Douglas is a scholar working on Health, Infectious Diseases and Sociology and Political Science. According to data from OpenAlex, Naomi Douglas has authored 6 papers receiving a total of 28 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Health, 3 papers in Infectious Diseases and 2 papers in Sociology and Political Science. Recurrent topics in Naomi Douglas's work include Vaccine Coverage and Hesitancy (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral Infections and Outbreaks Research (2 papers). Naomi Douglas is often cited by papers focused on Vaccine Coverage and Hesitancy (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral Infections and Outbreaks Research (2 papers). Naomi Douglas collaborates with scholars based in United Kingdom and Australia. Naomi Douglas's co-authors include Maria Moore, Samantha Vanderslott, Susanne H. Hodgson, Andrew J. Pollard, Katherine R. W. Emary, Arabella Stuart, Rebecca te Water Naudé, Maia Patrick-Smith, John A. Henry and Marcus Rex English and has published in prestigious journals such as Vaccine, Human Vaccines & Immunotherapeutics and Science Technology & Human Values.

In The Last Decade

Naomi Douglas

6 papers receiving 27 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomi Douglas United Kingdom 3 18 10 9 6 3 6 28
Maia Patrick-Smith United Kingdom 4 18 1.0× 10 1.0× 9 1.0× 8 1.3× 3 1.0× 6 32
Archchun Ariyarajah Canada 4 19 1.1× 11 1.1× 9 1.0× 5 0.8× 1 0.3× 7 33
Rebecca te Water Naudé United Kingdom 3 16 0.9× 8 0.8× 9 1.0× 4 0.7× 1 0.3× 7 32
Marcus Rex English United Kingdom 3 18 1.0× 10 1.0× 9 1.0× 5 0.8× 1 0.3× 5 26
Heather N. Graci United States 2 18 1.0× 5 0.5× 11 1.2× 8 1.3× 2 0.7× 3 25
Abubakar Kalinaki Uganda 2 12 0.7× 9 0.9× 7 0.8× 2 0.3× 2 0.7× 3 16
Aboubacar Soumah Belgium 2 12 0.7× 23 2.3× 4 0.4× 5 0.8× 1 0.3× 2 27
A. de Ruijter Netherlands 2 23 1.3× 8 0.8× 13 1.4× 4 0.7× 3 1.0× 5 26
Ugochukwu Anthony Eze Nigeria 4 25 1.4× 13 1.3× 13 1.4× 11 1.8× 2 0.7× 20 53
Michelle C. Davidson United States 3 5 0.3× 16 1.6× 4 0.4× 7 1.2× 1 0.3× 6 18

Countries citing papers authored by Naomi Douglas

Since Specialization
Citations

This map shows the geographic impact of Naomi Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Douglas more than expected).

Fields of papers citing papers by Naomi Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Douglas. The network helps show where Naomi Douglas may publish in the future.

Co-authorship network of co-authors of Naomi Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Douglas. A scholar is included among the top collaborators of Naomi Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Douglas. Naomi Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Patrick-Smith, Maia, Katherine R. W. Emary, Susanne H. Hodgson, et al.. (2024). Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial. Vaccine. 42(26). 126391–126391. 1 indexed citations
2.
Thomas, Tonia M., Susanne H. Hodgson, Katherine R. W. Emary, et al.. (2023). The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines. Human Vaccines & Immunotherapeutics. 19(1). 2203023–2203023. 1 indexed citations
3.
Vanderslott, Samantha, Katherine R. W. Emary, Rebecca te Water Naudé, et al.. (2021). Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom. BMJ Global Health. 6(10). e006305–e006305. 19 indexed citations
4.
Vanderslott, Samantha, Alexandra Palmer, Tonia M. Thomas, et al.. (2021). Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing. Science Technology & Human Values. 48(4). 909–937. 3 indexed citations
5.
Wang, Xin Maggie, et al.. (2019). Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study. Biopreservation and Biobanking. 17(6). 570–576. 2 indexed citations
6.
Douglas, Naomi. (2012). Befriending breastfeeding: a home-based antenatal pilot for south Asian families.. PubMed. 85(6). 28–31. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026